These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30746202)

  • 1. Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection.
    Liu Y; Shen J; Liu L; Shan L; He J; He Q; Jiang L; Guo M; Chen X; Pan H; Peng G; Shi H; Ou L; Liang W; He J
    J Thorac Dis; 2018 Dec; 10(12):6569-6577. PubMed ID: 30746202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
    Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer ≤2 cm.
    Cao J; Xu J; He Z; Yuan P; Huang S; Lv W; Hu J
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):796-805.e4. PubMed ID: 29716729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.
    Zhang B; Liu R; Ren D; Li X; Wang Y; Huo H; Zhu S; Chen J; Song Z; Xu S
    Front Oncol; 2021; 11():610638. PubMed ID: 34026604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.
    Lv X; Cao J; Dai X; Rusidanmu A
    Thorac Cancer; 2018 Aug; 9(8):1026-1031. PubMed ID: 29927089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
    Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
    Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.
    Guo J; Liu Y; Tian X; Ren Z; Lin J; Wang B; Liang C
    Mol Clin Oncol; 2019 Nov; 11(5):465-473. PubMed ID: 31620277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of lymphadenectomy on outcomes of sublobar resection for non-small cell lung cancer ≤1 or >1 to 2 cm.
    Zheng E; Yang M; Li R; Ni J; Xu X; Zhao G
    J Thorac Dis; 2020 May; 12(5):2049-2060. PubMed ID: 32642107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
    Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
    JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublobar resection versus definitive radiation in patients with stage IA non-small cell lung cancer.
    Fernandez FG; Crabtree TD; Liu J; Meyers BF
    Ann Thorac Surg; 2012 Aug; 94(2):354-60; discussion 360-1. PubMed ID: 22429673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer.
    Yang H; Li X; Shi J; Fu H; Yang H; Liang Z; Xiong H; Wang H
    Cancer Manag Res; 2018; 10():6611-6626. PubMed ID: 30584357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Altorki NK; Sedrakyan A
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):858-866. PubMed ID: 31168591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.
    Cox ML; Yang CJ; Speicher PJ; Anderson KL; Fitch ZW; Gu L; Davis RP; Wang X; D'Amico TA; Hartwig MG; Harpole DH; Berry MF
    J Thorac Oncol; 2017 Apr; 12(4):689-696. PubMed ID: 28082103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.